| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.093 | 0.07 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |